Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2

Journal of Biological Chemistry

Volumn 288, Issue 34, 2013, Pages 24590-24599

  Jiang, Kai ^a   Yang, Zhihong ^a   Cheng, Long ^a   Wang, Shibin ^b   Ning, Kang ^a,c   Zhou, Lei ^d   Lin, Jing ^b   Zhong, Hui ^a   Wang, Lisheng ^e   Li, Yang ^b   Huang, Junjian ^a   Zhang, Hao ^a   Ye, Qinong ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Liaoning Center for Disease Control and Prevention   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER CELLS; CANCER CELL GROWTH; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTORS; INTEGRATION OF FUNCTIONS; MITOGEN ACTIVATED PROTEIN KINASE; MOLECULAR MECHANISM; REGULATORY PROTEIN;

ENZYMES; GENE EXPRESSION; PROTEINS;

CELL SIGNALING;

CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; MEDIATOR OF ERBB2 DRIVEN CELL MOTILITY; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CELL ANCHORAGE; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ER GENE; ERBB2 GENE; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GROWTH REGULATION; HUMAN; HUMAN CELL; IGF1R GENE; IN VITRO STUDY; MEMO GENE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BREAST CANCER; CELL PROLIFERATION; ERBB2; ESTROGEN RECEPTOR; GROWTH FACTORS; IGF1R; MEMO; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NONHEME IRON PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN;

EID: 84883172818     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.467837     Document Type: Article

References (50)

1. Deroo, B. J., and Korach, K. S. (2006) Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570
2. Yager, J. D., and Davidson, N. E. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354, 270-282
3. Levin, E. R., and Pietras, R. J. (2008) Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res. Treat. 108, 351-361
4. Fu, X. D., and Simoncini, T. (2008) Extranuclear signaling of estrogen receptors. IUBMB Life 60, 502-510
5. Boonyaratanakornkit, V. (2011) Scaffolding proteins mediating membrane-initiated extranuclear actions of estrogen receptor. Steroids 76, 877-884
6. Pietras, R. J., and Márquez-Garbán, D. C. (2007) Membrane-associated estrogen receptor signaling pathways in human cancers. Clin. Cancer Res. 13, 4672-4676
7. Song, R. X., and Santen, R. J. (2006) Membrane initiated estrogen signaling in breast cancer. Biol. Reprod. 75, 9-16
8. Song, R. X., Chen, Y., Zhang, Z., Bao, Y., Yue, W., Wang, J. P., Fan, P., and Santen, R. J. (2010) Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells. J. Steroid Biochem. Mol. Biol. 118, 219-230
9. Thomas, R. S., Sarwar, N., Phoenix, F., Coombes, R. C., and Ali, S. (2008) Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity. J. Mol. Endocrinol. 40, 173-184
10. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494
11. Joel, P. B., Traish, A. M., and Lannigan, D. A. (1995) Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol. Endocrinol. 9, 1041-1052
12. Bunone, G., Briand, P. A., Miksicek, R. J., and Picard, D. (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183
13. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541
14. Martin, M. B., Franke, T. F., Stoica, G. E., Chambon, P., Katzenellenbogen, B. S., Stoica, B. A., McLemore, M. S., Olivo, S. E., and Stoica, A. (2000) A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141, 4503-4511
15. Marone, R., Hess, D., Dankort, D., Muller, W. J., Hynes, N. E., and Badache, A. (2004) Memo mediates ErbB2-driven cell motility. Nat. Cell Biol. 6, 515-522
16. Qiu, C., Lienhard, S., Hynes, N. E., Badache, A., and Leahy, D. J. (2008) Memo is homologous to nonheme iron dioxygenases and binds an ErbB2-derived phosphopeptide in its vestigial active site. J. Biol. Chem. 283, 2734-2740
17. Meira, M., Masson, R., Stagljar, I., Lienhard, S., Maurer, F., Boulay, A., and Hynes, N. E. (2009) Memo is a cofilin-interacting protein that influences PLCγ1 and cofilin activities, and is essential for maintaining directionality during ErbB2-induced tumor-cell migration. J. Cell Sci. 122, 787-797
18. Bazley, L. A., and Gullick, W. J. (2005) The epidermal growth factor receptor family. Endocr. Relat. Cancer 12, S17-27
19. Zaoui, K., Honoré, S., Isnardon, D., Braguer, D., and Badache, A. (2008) Memo-RhoA-mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells. J. Cell Biol. 183, 401-408
20. Zhang, H., Xie, X., Zhu, X., Zhu, J., Hao, C., Lu, Q., Ding, L., Liu, Y., Zhou, L., Liu, Y., Huang, C., Wen, C., and Ye, Q. (2005) Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. J. Biol. Chem. 280, 43188-43197
21. Burns, K. A., Li, Y., Arao, Y., Petrovich, R. M., and Korach, K. S. (2011) Selective mutations in estrogen receptorα D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. J. Biol. Chem. 286, 12640-12649
22. Ding, L., Wang, Z., Yan, J., Yang, X., Liu, A., Qiu, W., Zhu, J., Han, J., Zhang, H., Lin, J., Cheng, L., Qin, X., Niu, C., Yuan, B., Wang, X., Zhu, C., Zhou, Y., Li, J., Song, H., Huang, C., and Ye, Q. (2009) Human four-anda-half LIM family members suppress tumor cell growth through a TGF-β-like signaling pathway. J. Clin. Invest. 119, 349-361
23. Sun, Y., Ding, L., Zhang, H., Han, J., Yang, X., Yan, J., Zhu, Y., Li, J., Song, H., and Ye, Q. (2006) Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS. Nucleic Acids Res. 34, 6314-6326
24. Ding, L., Yan, J., Zhu, J., Zhong, H., Lu, Q., Wang, Z., Huang, C., and Ye, Q. (2003) Ligand-independent activation of estrogen receptor α by XBP-1. Nucleic Acids Res. 31, 5266-5274
25. Cheng, L., Li, J., Han, Y., Lin, J., Niu, C., Zhou, Z., Yuan, B., Huang, K., Li, J., Jiang, K., Zhang, H., Ding, L., Xu, X., and Ye, Q. (2012) PES1 promotes breast cancer by differentially regulating ERα and ERβ. J. Clin. Invest. 122, 2857-2870
26. Levin, E. R. (2005) Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19, 1951-1959
27. Stossi, F., Barnett, D. H., Frasor, J., Komm, B., Lyttle, C. R., and Katzenel-lenbogen, B. S. (2004) Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) α or ERβ in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145, 3473-3486
28. Creighton, C. J., Cordero, K. E., Larios, J. M., Miller, R. S., Johnson, M. D., Chinnaiyan, A. M., Lippman, M. E., and Rae, J. M. (2006) Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol. 7, R28
29. Frasor, J., Danes, J. M., Komm, B., Chang, K. C., Lyttle, C. R., and Katzenellenbogen, B. S. (2003) Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144, 4562-4574
30. Carroll, J. S., and Brown, M. (2006) Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. 20, 1707-1714
31. Song, R. X., Zhang, Z., Chen, Y., Bao, Y., and Santen, R. J. (2007) Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF7 breast cancer cells. Endocrinology 148, 4091-4101
32. Boulware, M. I., Kordasiewicz, H., and Mermelstein, P. G. (2007) Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J. Neurosci. 27, 9941-9950
33. Schlegel, A., Wang, C., Katzenellenbogen, B. S., Pestell, R. G., and Lisanti, M. P. (1999) Caveolin-1 potentiates estrogen receptor α (ERα) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERα. J. Biol. Chem. 274, 33551-33556
34. Lu, Q., Pallas, D. C., Surks, H. K., Baur, W. E., Mendelsohn, M. E., and Karas, R. H. (2004) Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proc. Natl. Acad. Sci. U.S.A. 101, 17126-17131
35. Cabodi, S., Moro, L., Baj, G., Smeriglio, M., Di Stefano, P., Gippone, S., Surico, N., Silengo, L., Turco, E., Tarone, G., and Defilippi, P. (2004) p130Cas interacts with estrogen receptor α and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell Sci. 117, 1603-1611
36. Song, R. X., Barnes, C. J., Zhang, Z., Bao, Y., Kumar, R., and Santen, R. J. (2004) The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 101, 2076-2081
37. Manavathi, B., Acconcia, F., Rayala, S. K., and Kumar, R. (2006) An inherent role of microtubule network in the action of nuclear receptor. Proc. Natl. Acad. Sci. U.S.A. 103, 15981-15986
38. Wang, X., Yang, Z., Zhang, H., Ding, L., Li, X., Zhu, C., Zheng, Y., and Ye, Q. (2008) The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim. Biophys. Acta 1783, 1220-1228
39. Fox, E. M., Andrade, J., and Shupnik, M. A. (2009) Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 74, 622-627
40. Osborne, C. K., Shou, J., Massarweh, S., and Schiff, R. (2005) Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin. Cancer Res. 11, 865s-870s
41. Murphy, L. C., Seekallu, S. V., and Watson, P. H. (2011) Clinical significance of estrogen receptor phosphorylation. Endocr. Relat. Cancer. 18, R1-R14
42. de Leeuw, R., Neefjes, J., and Michalides, R. (2011) A role for estrogen receptor phosphorylation in the resistance to tamoxifen. Int. J. Breast Cancer 232435:1-10
43. De, Luca, A., Maiello, M. R., D'Alessio, A., Pergameno, M., and Normanno, N. (2012) The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin. Ther. Targets 16, S17-S27
44. Milde-Langosch, K. (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41, 2449-2461
45. Lopez-Bergami, P., Lau, E., and Ronai, Z. (2010) Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat. Rev. Cancer 10, 65-76
46. Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., and Sutherland, R. L. (2011) CyclinDas a therapeutic target in cancer. Nat. Rev. Cancer 11, 558-572
47. Meyer, N., and Penn, L. Z. (2008) Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976-990
48. Mandal, S., and Davie, J. R. (2007) An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells. BMC Cancer 7, 1471-2407
49. Huang, X., Gao, L., Wang, S., McManaman, J. L., Thor, A. D., Yang, X., Esteva, F. J., and Liu, B. (2010) Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-I receptor in breast cancer cells resistant to herceptin. Cancer Res. 70, 1204-1214
50. Vogel, C., Chan, A., Gril, B., Kim, S. B., Kurebayashi, J., Liu, L., Lu, Y. S., and Moon, H. (2010) Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinib. Jpn. J. Clin. Oncol. 40, 999-1013